Naseem Zojwalla, M.D.

Naseem Zojwalla, M.D.

Chief Medical OfficeratOlema Pharmaceuticals· In proxies 2022–2024

Pay in FY2024+129% from the year before · Olema Pharmaceuticals stock -58.4% the same year

Naseem Zojwalla, M.D. was paid $3.0M in FY2024 (Dec), up 129%. Olema Pharmaceuticals stock fell 58.4% that year.

Pay$100 in the stock at the end of FY21 → $62
Pay is from the Summary Compensation Table of each Olema Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Olema PharmaceuticalsPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role -22%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?